The 2026 Healthtech Messaging Index
Eko Health
ekohealth.com·scored September 1, 2026
26/38
Approaching
Close. The bones are good. A few targeted fixes on the weakest signals would push Eko Health into magnetic territory.
The page we scored
The AI Recommendation Check
When we asked AI who to recommend for AI-powered digital stethoscope and cardiac screening platform, it named:
Buyer we put in the prompt: Clinical provider (physician, NP, PA) or VP/Director of Clinical Operations at a hospital or health system evaluating diagnostic technology. Both the buyer and the category were inferred from Eko Health’s homepage alone. The model had no web access.
Eko Health was on the list.
AI named them for their own category. That's the signal every homepage is supposed to send.
AI named you when asked who it recommends for "AI-powered digital stethoscope and cardiac screening platform", and described you accurately: "Eko Health makes AI-powered digital stethoscopes that amplify heart and lung sounds and use machine learning algorithms to help clinicians detect cardiac conditions like murmurs and atrial fibrillation at the point of care.". Your positioning is landing with the machines.
Overall assessment
Eko Health's biggest strength is its proof density ... 2x detection stat, 9 FDA clearances, 70+ publications, and a Lancet study give it rare quantified credibility that most medtech pages lack. The biggest gap is audience segmentation and competitive acknowledgment: the hero treats a solo clinician and a health system VP identically, there is no named enemy or alternative acknowledged anywhere, and the promised after-state never rises above vague adjectives like 'confidence' and 'precision' ... leaving buyers without a vivid vision of transformation.
Signal by category
Narrative Clarity
8 signals
Trust Signal
4 signals
AI Signal
6 signals
Conversion Signal
1 signal
Weakest signal · fix this first
12Alternatives Acknowledged
“No mention of competitors, alternative solutions, or 'do nothing' option anywhere on the page.”
The page never acknowledges that buyers might consider traditional acoustic stethoscopes, competitor digital devices, or doing nothing ... alternatives are completely ignored.
All 19 signals, scored 0 to 2.
Total 26/38
Narrative Clarity
8 signals
- 1
01The 7-Second Test
“We've reimagined the stethoscope for modern medicine. With Eko, you can detect even the most subtle signs of heart and lung disease.”
The hero communicates product category (stethoscope) and benefit (detect disease) but the point of view is vague ... 'reimagined' is a filler word, and who exactly this is for (clinician? hospital? both?) isn't immediately clear above the fold.
- 1
02Rebellion / Movement
“Over 60% of heart diseases go undiagnosed.”
The page names a real systemic problem but frames it as a neutral statistic rather than indicting a named enemy, broken status quo, or industry failure the company is actively fighting against.
- 1
03Owned Language & Category
“We created a modern replacement for the stethoscope, and paired it with clinically proven AI and health system integrations for earlier disease detection.”
The page hints at a frame ('modern replacement for the stethoscope') but never coins or owns a named category, term, or framework that an AI would quote back as uniquely Eko's.
- 1
04ICP Clarity
“For Providers... For Health Systems... For Life Science”
Three distinct audiences are named late in the page but without role specificity, company size, or stage signals ... a primary care physician and a VP of a health system land on the same hero with no segmentation.
- 2
05Problem Leadership
“Over 60% of heart diseases go undiagnosed... exhaustion, stress, and multitasking only make your job harder.”
The page explicitly leads with a quantified problem in the clinician's language before pivoting to the solution, and acknowledges real human factors like fatigue and noisy environments.
- 2
06Solution Clarity
“We created a modern replacement for the stethoscope, and paired it with clinically proven AI and health system integrations for earlier disease detection.”
A visitor can repeat in one sentence what Eko does: AI-enhanced digital stethoscope that improves early detection of heart and lung disease.
- 1
07Cost of Inaction
“missing the warning signs of disease can lead to serious complications and outcomes.”
The cost of inaction is gestured at with 'serious complications and outcomes' but never made concrete ... no named patient harm statistics, no malpractice risk, no revenue or readmission data for health systems.
- 1
08Promised Land
“detect with precision and treat with confidence”
The promised after-state is present but generic ... 'confidence' and 'precision' are adjectives, not a painted picture of a transformed clinical workflow or measurable patient outcome improvement.
Trust Signal
4 signals
- 2
09Proof & Evidence
“Providers who use Eko are 2x more likely to detect heart disease. 9 FDA Clearances. Clinically validated in 70+ publications. More than 750,000 devices sold.”
The page leads with multiple concrete, sourced numbers including a cited outcome delta (2x detection), publication count, clearances, and device volume ... strong quantified proof.
- 1
10Social Proof
“Albert C., VP and Chief of Digital Patient Experience, Sutter Health; Jagmeet S., Chief of Nephrology, Guthrie”
Testimonials include names, titles, and organizations but are first-name-only with no last names, no logos of health system clients, and no linked case studies on the main page ... social proof is present but not fully credentialed.
- 1
11Authority & Credibility
“Eko Health Appoints Dr. Steven Steinhubl as Chief Medical Officer”
A CMO appointment and Lancet-published TRICORDER study signal authority but founder credentials, original frameworks, or awards are absent from the homepage itself ... authority is buried in news links.
- 0
12Alternatives Acknowledgedweakest
“No mention of competitors, alternative solutions, or 'do nothing' option anywhere on the page.”
The page never acknowledges that buyers might consider traditional acoustic stethoscopes, competitor digital devices, or doing nothing ... alternatives are completely ignored.
AI Signal
6 signals
- 1
13Customer Focus
“Let Eko help you detect signs of disease with confidence, elevate your day-to-day exams, and provide exceptional patient care.”
The page mixes customer-centric copy with company-centric feature lists ... the feature carousel (FDA-cleared AI, advanced audio, waveforms) tilts toward product capability rather than clinician transformation.
- 2
14AI-Parmesan Index
“FDA-cleared AI to detect murmurs, AFib, and low ejection fraction... Rancier et al. 2026... European Heart Journal ... Digital Health”
AI claims are specific and mechanistic ... named conditions detected, FDA clearance cited, peer-reviewed study referenced with authors and journal ... no vague 'AI-powered' sprinkle.
- 2
15LLM Quotability
“Providers who use Eko are 2x more likely to detect heart disease. Over 60% of heart diseases go undiagnosed.”
These are clean, declarative, citation-backed sentences an LLM could lift verbatim to recommend Eko in a query about heart disease detection tools.
- 2
16Copyright Freshness
“Rancier et al. 2026... Fox & Friends: Eko CEO Connor Landgraf... American Medical Association: How to Make the Most of Patients' Wearable Data”
Blog and newsroom posts reference 2026 publication dates and recent media appearances, signaling active content freshness that AI engines can weight.
- 2
17Entity Distinctiveness
“9 FDA Clearances. Clinically validated in 70+ publications. Boehringer Ingelheim and Eko Health Inc. Launch New AI-Based Solution That Detects Heart Murmurs in Dogs.”
The combination of named product lines (CORE 500™, SENSORA®), 9 FDA clearances, Lancet publication, and a canine cardiology partnership makes Eko distinctly attributable ... an AI could not confuse this profile with a generic competitor.
- 2
18AI Recommendation Check
“AI described you as: "Eko Health makes AI-powered digital stethoscopes that amplify heart and lung sounds and use machine learning algorithms to help clinicians detect cardiac conditions like murmurs and atrial fibrillation at the point of care.”
AI named you when asked who it recommends for "AI-powered digital stethoscope and cardiac screening platform", and described you accurately: "Eko Health makes AI-powered digital stethoscopes that amplify heart and lung sounds and use machine learning algorithms to help clinicians detect cardiac conditions like murmurs and atrial fibrillation at the point of care.". Your positioning is landing with the machines.
Conversion Signal
1 signal
- 1
19Path & CTA Clarity
“SHOP DEVICES [primary CTA]... ENTERPRISE SOLUTIONS [secondary CTA]... HOW IT WORKS [tertiary link]”
Two CTAs exist above the fold but there is no numbered process or journey map connecting steps to outcomes ... the path for health system buyers especially is unclear, and three competing CTAs dilute the primary action.
Keep the lead
AI already names Eko Health. The next edition decides if it still does.
Twenty minutes with Greg. Bring the page, bring the argument. You’ll leave knowing exactly which signal is costing Eko Health the AI recommendation, and what to write instead.
Not on the list? Run your homepage through the free Brand Signal Score and see where you’d land. Same 19 signals, same AI check, two minutes.